We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
+3.39%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$661M
AUM Growth
-$473M
(-42%)
Cap. Flow
-$486M
Cap. Flow
% of AUM
-73.58%
Top 10 Holdings %
Top 10 Hldgs %
6.77%
Holding
1,175
New
248
Increased
83
Reduced
484
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$3.58M |
| 2 |
AutoZone
AZO
|
+$3.03M |
| 3 |
Howmet Aerospace
HWM
|
+$2.87M |
| 4 |
ANSS
Ansys
ANSS
|
+$2.84M |
| 5 |
Gartner
IT
|
+$2.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$7.61M |
| 2 |
General Motors
GM
|
+$6.29M |
| 3 |
Bunge Global
BG
|
+$5.38M |
| 4 |
Qualcomm
QCOM
|
+$5M |
| 5 |
US Foods
USFD
|
+$4.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.14% |
| 2 | Healthcare | 20.5% |
| 3 | Financials | 14.07% |
| 4 | Industrials | 12.62% |
| 5 | Consumer Discretionary | 11.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Parker-Hannifin
PH
$125B
| – | – |
-7,231
| Closed | -$1.78M |
|
1027
Phathom Pharmaceuticals
PHAT
$930M
| – | – |
-11,922
| Closed | -$101K |
|
1028
Dave & Buster's
PLAY
$361M
| – | – |
-36,337
| Closed | -$1.19M |
|
1029
Pliant Therapeutics
PLRX
$66.3M
| – | – |
-24,378
| Closed | -$195K |
|
1030
Playtika
PLTK
$1.51B
| – | – |
-42,779
| Closed | -$566K |
|
1031
Palantir
PLTR
$296B
| – | – |
-83,279
| Closed | -$755K |
|
1032
ePlus
PLUS
$2.42B
| – | – |
-16,635
| Closed | -$884K |
|
1033
Pool Corp
POOL
$7B
| – | – |
-3,492
| Closed | -$1.23M |
|
1034
Powell Industries
POWL
$7.32B
| – | – |
-38,157
| Closed | -$297K |
|
1035
Porch Group
PRCH
$1.38B
| – | – |
-14,945
| Closed | -$38K |
|
1036
Perdoceo Education
PRDO
$2.06B
| – | – |
-23,043
| Closed | -$271K |
|
1037
Protolabs
PRLB
$1.78B
| – | – |
-4,635
| Closed | -$222K |
|
1038
Phillips 66
PSX
$82.5B
| – | – |
-31,800
| Closed | -$2.61M |
|
1039
PubMatic
PUBM
$605M
| – | – |
-89,327
| Closed | -$1.42M |
|
1040
ProPetro Holding
PUMP
$1.31B
| – | – |
-32,367
| Closed | -$324K |
|
1041
PVH
PVH
$4.01B
| – | – |
-16,543
| Closed | -$941K |
|
1042
Perella Weinberg Partners
PWP
$1.18B
| – | – |
-35,212
| Closed | -$205K |
|
|
1043
Qualcomm
QCOM
$172B
| – | – |
-39,151
| Closed | -$5M |
|
1044
QuidelOrtho
QDEL
$1.14B
| – | – |
-10,825
| Closed | -$1.05M |
|
1045
Qiagen
QGEN
$8.72B
| – | – |
-21,339
| Closed | -$1.07M |
|
1046
QuinStreet
QNST
$916M
| – | – |
-42,542
| Closed | -$428K |
|
1047
Quad
QUAD
$434M
| – | – |
-24,470
| Closed | -$67K |
|
1048
The RealReal
REAL
$1.44B
| – | – |
-295,340
| Closed | -$735K |
|
1049
BRC Group Holdings
RILY
$270M
| – | – |
-35,022
| Closed | -$1.48M |
|
1050
Rimini Street
RMNI
$453M
| – | – |
-23,974
| Closed | -$144K |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
SGI
AAM
RSCM
PDT Partners's Q3 2022 Portfolio in Review
As of Q3 2022, PDT Partners held 1,175 positions worth $661M, down 42% from $1.13B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
PDT Partners withdrew a net $486M in Q3 2022, closing 358 positions and reducing 484 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $7.61M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, PDT Partners opened a new position in Coupang worth $3.45M.
- PDT Partners's largest Q3 2022 buy was Coupang: 207,142 shares worth $3.45M.
- PDT Partners added most to AutoZone in Q3 2022, an estimated $3.03M increase.
- PDT Partners's biggest Q3 2022 reduction was General Motors, cutting an estimated $6.29M.
- PDT Partners fully exited Vertex Pharmaceuticals in Q3 2022, selling an estimated $7.61M.
- PDT Partners's ten largest holdings make up 6.8% of its $661M portfolio in Q3 2022.
- PDT Partners opened 248 new positions and closed 358 in Q3 2022.
- PDT Partners's portfolio value fell 42% quarter-over-quarter to $661M.
Based on PDT Partners's 13F filing for Q3 2022, filed 14 Nov 2022.